Department of Chemistry, Center for Molecular Innovation and Drug Discovery, and Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois 60208-3113, USA.
J Am Chem Soc. 2010 Jan 20;132(2):798-806. doi: 10.1021/ja908544f.
The heme-thioether ligand interaction often occurs between heme iron and native methionine ligands, but thioether-based heme-coordinating (type II) inhibitors are uncommon due to the difficulty in stabilizing the Fe-S bond. Here, a thioether-based inhibitor (3) of neuronal nitric oxide synthase (nNOS) was designed, and its binding was characterized by spectrophotometry and crystallography. A crystal structure of inhibitor 3 coordinated to heme iron was obtained, representing, to our knowledge, the first crystal structure of a thioether inhibitor complexed to any heme enzyme. A series of related potential inhibitors (4-8) also were evaluated. Compounds 4-8 were all found to be type I (non-heme-coordinating) inhibitors of ferric nNOS, but 4 and 6-8 were found to switch to type II upon heme reduction to the ferrous state, reflecting the higher affinity of thioethers for ferrous heme than for ferric heme. Contrary to what has been widely thought, thioether-heme ligation was found not to increase inhibitor potency, illustrating the intrinsic weakness of the thioether-ferric heme linkage. Subtle changes in the alkyl groups attached to the thioether sulfur caused drastic changes in the binding conformation, indicating that hydrophobic contacts play a crucial role in stabilizing the thioether-heme coordination.
血红素硫醚配体相互作用通常发生在血红素铁和天然蛋氨酸配体之间,但由于难以稳定 Fe-S 键,基于硫醚的血红素配位(II 型)抑制剂并不常见。在这里,设计了一种基于硫醚的神经元型一氧化氮合酶 (nNOS) 抑制剂 (3),并通过分光光度法和晶体学对其结合进行了表征。获得了与血红素铁配位的抑制剂 3 的晶体结构,据我们所知,这代表了第一个与任何血红素酶配位的硫醚抑制剂的晶体结构。还评估了一系列相关的潜在抑制剂 (4-8)。发现化合物 4-8 均为铁 nNOS 的 I 型(非血红素配位)抑制剂,但 4 和 6-8 在血红素还原为亚铁态时变为 II 型,这反映了硫醚与亚铁血红素的亲和力高于与铁血红素。与人们普遍认为的相反,硫醚-血红素配位并没有增加抑制剂的效力,这说明了硫醚-铁血红素键的固有弱点。连接到硫醚硫上的烷基的细微变化导致结合构象发生剧烈变化,表明疏水性接触在稳定硫醚-血红素配位中起着至关重要的作用。